Aspirin ‘could help people improve cancer survival chances’

People being treated for cancer could potentially improve their survival prospects by taking aspirin, according to a new study.

The Cardiff University research conducted a review of existing research, including available data from five randomised trials and 42 observational studies of colorectal, breast and prostate cancers.

A significant reduction in mortality rates and the spread of cancer was seen among patients who took a low-level dose of aspirin in addition to their cancer treatment, with survival chances improving by up to 20 percent.

One key concern about taking aspirin regularly is the potential for intestinal bleeding, but this report identified no cases of serious or life-threatening bleeding among the patients involved.

More detailed research will now be needed to verify the findings of this study and to obtain evidence on less common cancers.

Study leader Professor Peter Elwood said: "We'd urge patients diagnosed with cancer to speak to their doctor about our findings so they can make an informed decision as to whether or not they should take a low-dose aspirin as part of their cancer treatment."